KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Assets (2016 - 2025)

Historic Return on Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • West Pharmaceutical Services' Return on Assets fell 200.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.13% for FY2024, which is 300.0% down from last year.
  • As of Q3 2025, West Pharmaceutical Services' Return on Assets stood at 0.12%, which was down 200.0% from 0.13% recorded in Q2 2025.
  • West Pharmaceutical Services' Return on Assets' 5-year high stood at 0.2% during Q1 2022, with a 5-year trough of 0.12% in Q3 2025.
  • In the last 5 years, West Pharmaceutical Services' Return on Assets had a median value of 0.15% in 2023 and averaged 0.16%.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 800bps in 2021, then tumbled by -600bps in 2023.
  • West Pharmaceutical Services' Return on Assets (Quarter) stood at 0.2% in 2021, then dropped by -18bps to 0.16% in 2022, then dropped by -7bps to 0.15% in 2023, then decreased by -14bps to 0.13% in 2024, then dropped by -9bps to 0.12% in 2025.
  • Its Return on Assets stands at 0.12% for Q3 2025, versus 0.13% for Q2 2025 and 0.12% for Q1 2025.